跳至主要内容
临床试验/NCT04497610
NCT04497610撤回不适用

SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem

Instituto Costarricense de Investigaciones Clínicas ICIC1 个研究点 分布在 1 个国家开始时间: 2022年11月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
Presence of disease

研究概览

简要总结

The purpose of the study is to verify the sensibility and accuracy of a rapid detection test for SARS-CoV-2 in breath samples analyzed by the breath detector analyzer TeraSystem, comparing with PCR tests.

详细描述

BioSafety Technologies has developed a rapid detection test to clear people of COVID-19.

A person can undergo an easy non-invasive test, to determine if they are: COVID-19 Clear (Negative) or Infected (Positive). The user-friendly process does not involve medically trained personnel.

The study will compare TeraSystem test results against PCR test results. Persons participating will be persons having a PCR test as part of the Health System and consenting to participate.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
7 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Older than 7 years odf age Able to provide informed consent Able to take the breath test

排除标准

  • Younger than 7 years of age Unable to provide informed consent Unable to take the breath test

结局指标

主要结局

Presence of disease

时间窗: 1 minute

Established diagnosis

次要结局

未报告次要终点

研究者

发起方
Instituto Costarricense de Investigaciones Clínicas ICIC
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Guillermo Rodríguez Gómez

Founder

Instituto Costarricense de Investigaciones Clínicas ICIC

研究点 (1)

Loading locations...

相似试验